Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · IEX Real-Time Price · USD
24.77
+0.21 (0.88%)
Mar 28, 2024, 11:10 AM EDT - Market open
Bicycle Therapeutics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for BCYC stock have an average target of 48.11, with a low estimate of 32 and a high estimate of 65. The average target predicts an increase of 94.27% from the current stock price of 24.77.
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 21, 2024.
Analyst Ratings
The average analyst rating for BCYC stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 5 | 5 |
Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 8 | 8 | 8 | 9 | 9 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Canaccord Genuity | Canaccord Genuity | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +142.28% | Feb 21, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $57 → $55 | Strong Buy | Maintains | $57 → $55 | +122.09% | Feb 21, 2024 |
Needham | Needham | Strong Buy Reiterates $43 | Strong Buy | Reiterates | $43 | +73.63% | Feb 21, 2024 |
JMP Securities | JMP Securities | Buy Maintains $44 → $32 | Buy | Maintains | $44 → $32 | +29.21% | Dec 20, 2023 |
Needham | Needham | Strong Buy Maintains $46 → $43 | Strong Buy | Maintains | $46 → $43 | +73.63% | Dec 15, 2023 |
Financial Forecast
Revenue This Year
28.03M
from 26.98M
Increased by 3.92%
Revenue Next Year
24.15M
from 28.03M
Decreased by -13.84%
EPS This Year
-5.29
from -5.08
EPS Next Year
-5.63
from -5.29
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 56.1M | 57.8M | 110.2M | 677.2M | 955.1M |
Avg | 28.0M | 24.2M | 43.5M | 223.7M | 450.4M |
Low | 9.8M | n/a | n/a | 53.6M | 88.4M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 107.9% | 106.0% | 356.0% | 1,456.5% | 326.9% |
Avg | 3.9% | -13.8% | 80.1% | 414.3% | 101.3% |
Low | -63.7% | - | - | 23.2% | -60.5% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -4.65 | -4.82 | -4.61 | 5.85 | 10.38 |
Avg | -5.29 | -5.63 | -5.59 | -3.70 | 1.02 |
Low | -5.78 | -6.91 | -7.35 | -9.26 | -7.29 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.